FindTrial
Sign In

Comparison of Ropivacaine and Bupivacaine during spinal anesthesia in leg surgery

“Comparison of effectiveness and safety of hyperbaric Ropivacaine(0.5%) with hyperbaric Bupivacaine(0.5%) in subarachnoid blockade in patients undergoing lower limb surgeries-prospective Double blind randomised controlled trial"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052684
Enrollment
144
Registered
2023-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S72- Fracture of femur Health Condition 2: S82- Fracture of lower leg, including ankle

Interventions

Intervention1: Ropivacaine: 0.5% hyperbaric Ropivacaine, 3 cc through subarachnoid space using lumbar puncture needle before surgery Control Intervention1: Bupivacaine: 0.5% hyperbaric Bupivacaine,

Sponsors

Priyanga ravi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient undergoing lower limb surgeries under subarachnoid blockade. 2.Age group:18-80 years 3.Patients with ASA (I/II).

Exclusion criteria

Exclusion criteria: 1.Patients undergoing spinal +epidural anaesthesia. 2.Orthopaedic surgeries of longer duration which will be required epidural anaesthesia.

Design outcomes

Primary

MeasureTime frame
efficacy of anesthesia, sensory and motor blockade, hemodynamic changesTimepoint: 1 hour, 2 hour, 4 hour and 8 hour after giving anesthesia—

Secondary

MeasureTime frame
post operative adverse effects like nausea vomiting, hypotension, bradycardia and shiveringTimepoint: postoperative 24 hours—

Countries

India

Contacts

Public ContactDr Lopa Trivedi

Government medical college and sir T hospital Bhavanagar

trivedi_lopa@yahoo.in9428009958

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026